Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Accumulated Depreciation (2024 - 2025)

Historic Accumulated Depreciation for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to $623000.0.

  • CG Oncology's Accumulated Depreciation changed N/A to $623000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $623000.0, marking a year-over-year change of. This contributed to the annual value of $87000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Accumulated Depreciation is $623000.0.
  • CG Oncology's 5-year Accumulated Depreciation high stood at $623000.0 for Q3 2025, and its period low was $87000.0 during Q4 2024.